Showing papers by "Rodney Harris published in 1991"

Extended MHC haplotypes and CYP21/C4 gene organisation in Irish 21-hydroxylase deficiency families.

Abstract: We have analysed fifteen classical 21-hydroxylase deficiency families from throughout Southern Ireland and report the serologically defined HLA-A, HLA-B, HLA-Cw, HLA-DR, C4A and C4B polymorphisms that characterize the inferred disease haplotypes. Additionally, we have used a combination of short and long range restriction mapping procedures in order to characterize the CYP21/C4 gene organization associated with individual serologically defined haplotypes. The results obtained indicate that disease haplotypes are characterized by a high frequency (33%) of CYP21B gene deletion and 8 out of 10 such deletion haplotypes are represented by the extended haplotype HLA-DR1, C4BQo, C4A3, HLA-B40(w60), HLA-Cw3, HLA-A3. Large scale length polymorphism in the CYP21/C4 gene cluster was found to conform strictly to a variable number of tandem repeats model with 4 alleles being detected. Disease haplotypes in which defective CYP21B gene expression is inferred to result from pathological point mutations show extensive diversity of associated HLA markers and include two examples of the extended HLA haplotype HLA-DR3, B8, Cw7, A1 haplotype, which has previously been reported to be negatively associated with 21-hydroxylase deficiency. One unusual disease haplotype has two CYP21 + C4 units, both of which appear to contain CYP21B-like genes.

How well do we manage families with genetic problems

Abstract: I Wellens HJJ, Brugada P, Penn OC, Gorgels AP, Smeets J. Pre-excitation svndromes: clinical presentation, course and therapy. In: Zipes DP, Jalife J, eds. Cardiac electrophvsiology: from cell to bedside. Philadelphia: W B Saunders, 1990:691-702. 2 Klein GJ, Bashore TM, Sellers TD, Pritchett ELC, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl3' Med 1979;301:1080-5. 3 Cox JL, Gallagher JJ, Cain ME. Experience with 118 consecutive patients undergoing operation for the Wolff-Parkinson-White syndrome. J7 Cardiovasc Surg 1985;90:490-501. 4 Fisher JD, Brodman R, Kim SG. Matos JA, Brodman LE, Wallerson D, Waspe LE. Attempted nonsurgical electrical ablation of accessorv pathways sia the coronary sinus in the WolffParkinson-White syndrome. J Am Coll Cardiol 1984;4:685-94. 5 Ward DE, Camm AJ. Treatment of tachycardias associated with the Wolff Parkinson White syndrome by transvenous electrical ablation of accessory pathways. Br Heart) 1985;53:64-8. 6 Bardy GH, Ivey TD, Stewart RBC, Johnson G, Greene HL. Developments, complications and limitations of catheter-mediated electrical ablation of posterior accessory atrioventricular pathways. Am 7 Cardiol 1988;61:309-16. 7 Morady F, Scheinman MM, Kou WH, Griffin JC, Dick M, Herre J, et al. Long-term results of catheter ablation of a posteroseptal accessory atrioventricular connection in 48 patients. Circulation 1989;79: 1160-70. 8 Warin JF, Haisaguerre M, D'Ivernois C, Lematayer P, Montserrat P. Catheter ablation of accessory pathways: technique and results in 248 patients. PACE 1990;13:1609-14. 9 Evans GT Jr, Scheinmann MM, Zipes DP, and Executive Committee of the Registry. The percutaneous cardiac mapping and ablation registry: final summary of results. PACE 1988;11: 1621-6. 10 Cunningham D, Rowland E, Rickards AF. A new low energy power source for catheter ablation. PACE 1986;9:1389-90. 11 Lemery R, Talajic M, Roy D, Coutu B, Lavalee E, Cartier R. Low energy DC ablation in patients with the Wolff-Parkinson-White syndrome: clinical outcome according to accessory pathway location [abstract]. PACE 1991;14(4 Pt II):670. 12 Borgreffe M, Budde T, Podczeck A, Breithardt G. High frequency alternating current ablation of an accessory pathway in humans. JAm Coll Cardiol 1987;10:576-82. 13 Huang SK. Advances in application of radiofrequency current to catheter ablation therapy. PACE 1991;14:28-42. 14 Jackman W, Wang X, Friday KJ, Roman CA, Moulton KP, Beckman KJ, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N EnglJ7 Med 1991;324:16051l. 15 Kuck K-H, Schluter M, Geiger M, Siebels J, Duckreck W. Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet 1992;337:1557-61. 16 Calkins H, Sousa J, El-Atassi R, Rosenheck S, De Buitleir M, Kou WG, et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single, electrophysiologic test. N EnglJ Med 1991;324:1612-8. 17 Langberg JJ, Chin M, Schamp DJ, Lee MA, Goldberger J, Pederson DN, et al. Ablation of the atrioventricular junction with radiofrequency energy using a new electrode catheter. Am J Cardiol 1991;67:142-7. 18 Ruskin JN. The cardiac arrhythmia suppression trial (CAST). N Englj Med 1989;321:386-8. 19 De Buitleir M, Sousa J, Calkins H, Bolling SF, El Atassi R, Kou WH, et al. Dramatic reduction in medical care costs associated with radiofrequency catheter ablation of accessory pathways [abstract]. 7 Am Coll Cardiol 1991;17(suppl A): 109.